Harvard university- COMMEMORATION of the 30th ANNIVERSARY of the Genocide AGAINST the Tutsi-April 16th, 2024
Michael Fairbanks shares the panel with Rwanda's leading human rights attorney, Florida Kabasinga; two Rwandan presidential fellows, and Harvard historian and biographer of Paul Kagame, Jonathan Hansen. Mike spoke about how that crisis galvanizes the Rwandan people.
European investment Bank, LUXEMBOURG, March 12, 2024
EIB senior finance and science officials, chief investment officer of the RSSB, and Akagera Medicines founders begin formal relationship and sign €2 million grant to begin clinical trials and build out operations in Rwanda.
Rwanda Day, February 3, 2024 Washington DC
Rwanda Biotech Czar, Mauro DeLorenzo; Akagera Medicines Founding Investor, Suzanne Wright; President Paul Kagame, and Chairman of Rwandan-owned, Akagera Medicines, Michael Fairbanks.
CEPI partners with Rwandan-owned Akagera Medicines to improve the delivery and accessibility of mRNA vaccines.
Representatives from the European Investment Bank, the Rwandan Ministry of Health, the Rwandan Social Security Board, and CEPI - join the principals of Akagera Medicines on stage for the press announcement.
Akagera Founders meet Biontech co-founder in Kigali-December 18th, 2023
Michael Fairbanks, Dr. Özlem Türeci, Dr. Daryl Drummond, and Ambassador Albrecht Conze at the opening of the BIONTECH manufacturing facility.
CNBC, Africa interview with AKAGERA Med’s CSO, Dr. Daryl Drummond, PhD
🇷🇼 CEPI announced a new partnership with Rwanda-owned Akagera Medicines.
CEPI was founded by the G-7, the Gates Foundation, and the governments of India and Norway. The partnership will advance the development of Akagera Medicines' innovative lipid nanoparticles and modified mRNA technology.
The center for epidemic preparedness innovations (CEPI) travels to Kigali
Akagera’s own Daryl and Jackie Drummond have been a part of this project since 2018.
Read the article at World Vision
2023 East african pharma & biotech conference
Michael C. Fairbanks & Dr. Ross Fulton (middle and right)
June 13-14 Kigali Convention Center
Kigali, Rwanda
2023 East african pharma & Biotech Conference
MIchael C. Fairbanks talks to the crowd.
June 13-14 Kigali Convention Center
Kigali, Rwanda
President Kagame joined residents of the City of Kigali for Car Free Day on September 4th, 2022.
The mass sports program, Car Free Day, takes place every other Sunday morning, closing down roads in the city and dedicating them to walkers, joggers, cyclists and others.
The President wore his Akagera Medicines cap for his walk.
Members of Akagera Medicines community attend President Kagame’s Advisory Council meeting during the 2022 United Nations General Assembly week in New York City.
Dr. Eliane Ubalijoro (left), Dr. Donald Kaberuka, and Michael Fairbanks (right).
Akagera Medicines registers a 100% owned subsidiary in Rwanda and hosts the European Investment Bank, June 2022.
Principals from Akagera Medicines host the team from the European Investment Bank (headquartered in Luxembourg) at the site of the biotechnology industrial park outside of Kigali.
From left to right: Karsten Fuelster, EX- IFC banker and member of the Akagera Medicines board of advisors; Michael Fairbanks (kneeling), co-founder and executive chairman; German Ambassador (ret.) Dr. Albrecht Conze, board director; Dr. Valeria Iansante, PhD, EIB scientist; Dr. Daryl Drummond, PhD, co-founder and CSO; Dr. Anna Lynch, life science specialist, EIB; and Antonin Calzarossa, Investment Officer, EIB.
Discussion taking place with Rwandan Health Minister, Dr. Ngamije, over the possibility of EIB funding for Akagera Medicines initiatives in Africa.
EIB and Akagera Medicines team consult with Minister of Health of Rwanda, Dr. Daniel Ngamije, MD (farthest right).
Professor Bienvenu explains the concept of “additionality” and what biotechnology will mean for the Rwandan people.
EIB bankers and Akagera Medicines chief science officer, Dr. Daryl Drummond PhD are briefed by the leader of the Rwanda Food and Drug administration, Dr. Emile Bienvenu, PhD.